SPY337.00+2.11 0.63%
DIA278.22+0.72 0.26%
IXIC11,332.86+165.35 1.48%

Brickell Biotech On Aug. 17 Received Notice From Nasdaq Listing Qualifications Department

On August 17, 2020, Brickell Biotech, Inc. (the “Company”) received a notice from the Listing Qualifications Department (the “Staff”) of the Nasdaq Stock Market(“Nasdaq”) informing the

Benzinga · 08/21/2020 20:21

On August 17, 2020, Brickell Biotech, Inc. (the “Company”) received a notice from the Listing Qualifications Department (the “Staff”) of the Nasdaq Stock Market(“Nasdaq”) informing the Company that because the closing bid price for the Company’s common stock listed on Nasdaq was below $1.00 per share for 30 consecutivebusiness days, the Company does not comply with the minimum closing bid price requirement for continued listing on The Nasdaq Capital Market under Nasdaq MarketplaceRule 5550(a)(2) (the “Rule”). The notification has no immediate effect on the listing of the Company’s common stock.In accordance with Nasdaq’s Listing Rules, the Company has a period of 180 calendar days, or until February 16, 2021, to regain compliance with the Rule. If at anytime during this 180-day period, the closing bid price of the Company’s common stock is at least $1.00 per share for a minimum of 10 consecutive business days, Nasdaq willprovide written confirmation that the Company has achieved compliance with the Rule.